Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: A cross-sectional and longitudinal study

American Journal of Clinical Dermatology

Volumn 13, Issue 1, 2012, Pages 37-47

  Coimbra, Susana ^a,b,c   Oliveira, Hugo ^d   Reis, Flávio ^e   Belo, Luís ^a,b   Rocha, Susana ^a,b   Quintanilha, Alexandre ^a,b   Figueiredo, Américo ^d   Teixeira, Frederico ^e   Castro, Elisabeth ^a,b   Rocha Pereira, Petronila ^b,f   Santos Silva, Alice ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Polytechnic Health Institute of North   (Portugal)

^d CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

^f UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

5 methoxypsoralen; Betamethasone dipropionate; Calcipotriol; Erythrocytes; Photochemotherapy; Phototherapy; Plaque psoriasis

Indexed keywords

ACUTE PHASE PROTEIN; ANTIOXIDANT; BILIRUBIN; C REACTIVE PROTEIN; ELASTASE; HEMOGLOBIN; LACTOFERRIN; MEMBRANE PROTEIN; MONOMER; PROTEINASE; PSORALEN; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL AGGREGATION; CELL ASSAY; CELL DAMAGE; CHRONIC DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME BLOOD LEVEL; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; ERYTHROID CELL; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LIPID PEROXIDATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUTROPHIL COUNT; PHOTOCHEMOTHERAPY; PORTUGAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; PUVA; RETICULOCYTE; RETICULOCYTE COUNT; TOPICAL TREATMENT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ADULT; BETAMETHASONE; CALCITRIOL; CROSS-SECTIONAL STUDIES; DERMATOLOGIC AGENTS; ERYTHROID CELLS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PSORIASIS; ULTRAVIOLET THERAPY;

EID: 84055190900     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11592110-000000000-00000     Document Type: Article

References (57)

1. Rocha-Pereira P, Santos-Silva A, Rebelo I, et al. The inflammatory response in mild and in severe psoriasis. Br J Dermatol 2004 May; 150 (5): 917-28 (Pubitemid 38903524)
2. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005 Mar; 64 Suppl. 2: ii30-6 (Pubitemid 40288517)
3. Krueger G, Ellis CN. Psoriasis: recent advances in understanding its pathogenesis and treatment. JAmAcad Dermatol 2005 Jul; 53 (1 Suppl. 1): S94-100 (Pubitemid 40828186)
4. Chowaniec O, Jablonska S, Beutner EH, et al. Earliest clinical and histological changes in psoriasis. Dermatologica 1981; 163 (1): 42-51 (Pubitemid 11094542)
5. Orem A, Deger O, Cimsit G, et al. Plasma polymorphonuclear leukocyte elastase levels and its relation to disease activity in psoriasis. Clin Chim Acta 1997 Aug 8; 264 (1): 49-56 (Pubitemid 27336992)
6. Arican O, Aral M, Sasmaz S, et al. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005 Oct 24; 2005 (5): 273-9 (Pubitemid 41577417)
7. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation 2006 May 2; 113 (17): 2128-34; discussion 51
8. Yeh ET. CRP as a mediator of disease. Circulation 2004 Jun 1; 109 (21 Suppl. 1): II11-4 (Pubitemid 38724150)
9. Friedewald VE, Cather JC, Gelfand JM, et al. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 2008 Dec 15; 102 (12): 1631-43
10. Friedewald Jr VE, Cather JC, Gordon KB, et al. The editor's roundtable: psoriasis, inflammation, and coronary artery disease. Am J Cardiol 2008 Apr 15; 101 (8): 1119-26
11. Pelle E, Mammone T, Maes D, et al. Keratinocytes act as a source of reactive oxygen species by transferring hydrogen peroxide to melanocytes. J Invest Dermatol 2005 Apr; 124 (4): 793-7 (Pubitemid 40489507)
12. Rocha-Pereira P, Santos-Silva A, Rebelo I, et al. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol 2004 Feb; 150 (2): 232-44 (Pubitemid 38352460)
13. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 2007 Aug 13-27; 167 (15): 1670-5 (Pubitemid 47280349)
14. Shirai K. Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Curr Med Res Opin 2004 Mar; 20 (3): 295-304 (Pubitemid 38339170)
15. Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007 Oct; 157 (4): 649-55 (Pubitemid 47389868)
16. Coimbra S, Oliveira H, Reis F, et al. Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. J Dermatol Sci 2009 Sep; 55 (3): 202-4
17. Panagiotakos DB, Pitsavos C, Yannakoulia M, et al. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 2005 Dec; 183 (2): 308-15 (Pubitemid 41579282)
18. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003 Dec; 112 (12): 1785-8 (Pubitemid 38063699)
19. Rao GM, Morghom LO. Effect of obesity on erythrocyte count and hemoglobin levels in Libyan diabetic patients. Clin Physiol Biochem 1986; 4 (4): 277-80 (Pubitemid 16003356)
20. Lutz HU. Erythocyte clearance. In: Harris J, editor. Blood cell biochemistry. New York (NY): Plenum Press, 1990: 81
21. KayMM. Role of physiologic autoantibody in the removal of senescent human red cells. J Supramol Struct 1978; 9 (4): 555-67 (Pubitemid 9147295)
22. Kay MM. Localization of senescent cell antigen on band 3. Proc Natl Acad Sci U S A 1984 Sep; 81 (18): 5753-7 (Pubitemid 14023842)
23. Kay MM, Goodman SR, Sorensen K, et al. Senescent cell antigen is immunologically related to band 3. Proc Natl Acad Sci U S A 1983 Mar; 80 (6): 1631-5 (Pubitemid 13052463)
24. Bosman GJ, Werre JM, Willekens FL, et al. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008 Dec; 18 (6): 335-47
25. Lutz HU, Bussolino F, Flepp R, et al. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc Natl Acad Sci U S A 1987 Nov; 84 (21): 7368-72 (Pubitemid 18035707)
26. Lutz HU. Naturally occurring anti-band 3 antibodies. Transfus Med Rev 1992 Jul; 6 (3): 201-11
27. Low PS. Role of hemoglobin denaturation and band 3 clustering in initiating red cell removal. In: Magnani M, De Flora A, editors. Red blood cell aging. New York (NY): Plenum Press, 1991: 173-83
28. Santos-Silva A, Rebelo MI, Castro EM, et al. Leukocyte activation, erythrocyte damage, lipid profile and oxidative stress imposed by high competition physical exercise in adolescents. Clin Chim Acta 2001 Apr; 306 (1-2): 119-26 (Pubitemid 32244333)
29. Santos-Silva A, Rebelo I, Castro E, et al. Erythrocyte damage and leukocyte activation in ischemic stroke. Clin Chim Acta 2002 Jun; 320 (1-2): 29-35 (Pubitemid 34450818)
30. Belo L, Rebelo I, Castro EM, et al. Band 3 as a marker of erythrocyte changes in pregnancy. Eur J Haematol 2002 Sep; 69 (3): 145-51 (Pubitemid 35335151)
31. Coimbra S, Castro E, Rocha-Pereira P, et al. The effect of green tea in oxidative stress. Clin Nutr 2006 Oct; 25 (5): 790-6 (Pubitemid 44426430)
32. Catarino C, Rebelo I, Belo L, et al. Erythrocyte changes in preeclampsia: relationship between maternal and cord blood erythrocyte damage. J Perinat Med 2009; 37 (1): 19-27
33. Rocha S, Vitorino RM, Lemos-Amado FM, et al. Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells Mol Dis 2008 Jul-Aug; 41 (1): 5-9
34. Costa E,Rocha S, Rocha-Pereira P, et al. Band 3 profile as amarker of erythrocyte changes in chronic kidney disease patients. Open Clin Chem J 2008; 1: 57-63
35. Santos-Silva A, Castro EM, Teixeira NA, et al. Altered erythrocyte membrane band 3 profile as a marker in patients at risk for cardiovascular disease. Atherosclerosis 1995 Aug; 116 (2): 199-209
36. Santos-Silva A, Castro EM, Teixeira NA, et al. Erythrocyte membrane band 3 profile imposed by cellular aging, by activated neutrophils and by neutrophilic elastase. Clin Chim Acta 1998 Jul 28; 275 (2): 185-96 (Pubitemid 28323075)
37. Gornicki A, Gutsze A. Erythrocyte membrane fluidity changes in psoriasis: an EPR study. J Dermatol Sci 2001 Sep; 27 (1): 27-30 (Pubitemid 32655425)
38. Gornicki A. Domain structure of erythrocyte membranes in psoriasis: an EPR study. J Dermatol Sci 2002 Sep; 29 (3): 214-21 (Pubitemid 35375278)
39. Corrocher R, Bassi A, Gandini A, et al. Transmembrane cation fluxes and fatty acid composition of erythrocytes in psoriatic patients. Clin Chim Acta 1990 Jan 31; 186 (3): 335-44 (Pubitemid 20040317)
40. Schopf RE, Langendorf Y, Benz RE, et al. A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis. J Invest Dermatol 2002 Jul; 119 (1): 160-5 (Pubitemid 35304405)
41. Shimizu T, Takakuwa Y, Koizumi H, et al. Localization of immuno-analogues of erythrocyte protein 4.1 and spectrin in epidermis of psoriasis vulgaris. Histochem Cell Biol 1995 May; 103 (5): 363-8
42. Lebwohl M, Feldman SR, Walther R, et al. Clinical management of psoriasis: principles and practice. Cutis 2001 Jan; 67 (1 Suppl.): 1-15
43. Frederiksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44 (Pubitemid 8387357)
44. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963 Jan; 100: 119-30
45. BradfordMM.Arapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 May 7; 72: 248-54
46. Niehaus Jr WG, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968 Oct 17; 6 (1): 126-30
47. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 Aug 15; 227 (5259): 680-5
48. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979 Sep; 76 (9): 4350-4 (Pubitemid 9256559)
49. Czerwinski M, Wasniowska K, Steuden I, et al. Degradation of the human erythrocyte membrane band 3 studied with monoclonal antibody directed against an epitope on the cytoplasmic fragment of band 3. Eur J Biochem 1988 Jul 1; 174 (4): 647-54
50. Mamus SW, Beck-Schroeder S, Zanjani ED. Suppression of normal human erythropoiesis by gamma interferon in vitro: role of monocytes and T lymphocytes. J Clin Invest 1985 May; 75 (5): 1496-503 (Pubitemid 15041441)
51. Means Jr RT, Krantz SB. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest 1993 Feb; 91 (2): 416-9 (Pubitemid 23064122)
52. Lebwohl M, Ali S. Treatment of psoriasis: part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001 Oct; 45 (4): 487-98; quiz 499-502
53. Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: traditional therapy. Ann Rheum Dis 2005 Mar; 64 Suppl. 2: ii83-6 (Pubitemid 40288530)
54. Silny W, Pehamberger H, Zielinsky C, et al. Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis. J Invest Dermatol 1980 Aug; 75 (2): 187-8 (Pubitemid 10087361)
55. Kapuscinska R, Wysocka J, Niczyporuk W, et al. Cytofluorimetric assay for evaluation of CD16 receptor expression and myeloperoxidase (MPO) activity of neutrophils in patients with psoriasis vulgaris treated with PUVA. Wiad Lek 2004; 57 (11-12): 599-602
56. Bredberg A, Forsgren A. Effects of in vitro PUVA on human leukocyte function. Br J Dermatol 1984 Aug; 111 (2): 159-68 (Pubitemid 14052297)
57. Piskin G, Tursen U, Bos JD, et al. IL-4 expression by neutrophils in psoriasis lesional skin upon high-dose UVB exposure. Dermatology 2003; 207 (1): 51-3 (Pubitemid 36829053)